Treprostinil Data to be Presented at Annual Meeting of the American Thorac... ( United Therapeutics to Hold Investo...)

Treprostinil Data to be Presented at Annual Meeting of the American Thoracic Society

Date:5/6/2008

United Therapeutics to Hold Investor Q&A Session Following Conclusion of

ATS Conference

SILVER SPRING, Md., May 6 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) and its wholly-owned subsidiary Lung Rx, Inc. today announced that data related to the four different routes of administration of the drug, treprostinil, for the treatment of pulmonary arterial hypertension will be presented at the annual meeting of the American Thoracic Society (ATS), to be held in Toronto, Ontario, beginning May 16th and ending May 21, 2008, including the first public presentation of the full data set from the TRIUMPH-1 study of inhaled treprostinil. Additional information concerning presentation topics and times may be accessed via the ATS conference website or at http://ir.unither.com/events.cfm.

United Therapeutics will host an investor Q&A session following the conclusion of the ATS conference at The Westin Harbour Castle, One Harbour Square, Toronto, Ontario, on May 21, 2008, at 5:00 pm EDT. Lewis Rubin, MD, Director of the Pulmonary Hypertension Program at the University of California San Diego, and Vallerie McLaughlin, MD, Director of the Pulmonary Hypertension Program at the University of Michigan, will participate in this Q&A session, which is also being webcast and can be accessed via United Therapeutics' website at http://ir.unither.com/events.cfm.

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening ca
'/>"/>

SOURCE United Therapeutics Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting
2. Phase 3 Data Regarding Anti-RSV Antibody To Be Presented at Pediatric Academic Societies (PAS) Annual Meeting
3. Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL
4. Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL)
5. Data Presented at AAN Support Potential for Adjunctive use of Intravenous Lacosamide as Short-Term Replacement for Oral Treatment in Partial Epilepsy
6. Data Presented at the American Academy of Neurology Show XP13512/GSK1838262 Significantly Improved Symptoms of Moderate-to-Severe Primary Restless Legs Syndrome
7. Data Presented at AAN Show That Lacosamide Significantly Reduced Pain and was Generally Well Tolerated in Patients With Diabetic Neuropathic Pain
8. Preclinical Study Presented at AACR Annual Meeting Shows Peregrines Anti-PS Immunocytokines Can Generate Protective Immune Responses in a Highly Aggressive Breast Cancer Model
9. Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95% and Halts Metastasis in a Model of Hormone-Refractory Prostate Cancer
10. Preclinical Study Presented at AACR Annual Meeting Shows Broad Anti-Cancer Potential of Peregrines anti-PS Vascular Targeting Antibodies
11. Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting

Post Your Comments:

(Date:12/16/2009)... Scientific Corporation (NYSE: BSX ) today announced ... Connors as a Director. ,, Ms. Connors, ... division of Tyco International. Previously, she served as ... operations and general management. Prior to Eaton, Ms. ... management capacities with Ford, Chrysler and Mogami Denki, a ...

(Date:12/16/2009)... Dec. 16 CareCentrix, Inc ., ... management services, announced today that it has been ... DC-based health care accrediting organization that establishes quality ... guarantee that only appropriately trained, qualified clinical personnel ... a reasonable and timely appeals process is in ...

(Date:12/16/2009)... Greenway Medical Technologies, Inc. today announced that its ... management and interoperability solution, Prime Suite® 2011, ... annual 2009 Top 20 Best in KLAS ... ,, For practices having between six and 25 ... in KLAS in ambulatory EMR for the fourth ...

Breaking Medicine Technology:Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 2 Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 3 CareCentrix Receives URAC Health Utilization Management Accreditation 2 Greenway Medical Technologies' PrimeSuite Wins Three Best in KLAS Awards 2 Greenway Medical Technologies' PrimeSuite Wins Three Best in KLAS Awards 3 Greenway Medical Technologies' PrimeSuite Wins Three Best in KLAS Awards 4 Savient Pharmaceuticals Announces Proposed Public Offering of Common Stock 5303 1 Savient Pharmaceuticals Announces Proposed Public Offering of Common Stock 5303 2 CPhI 2009 3A Madrid Launch for BioPh Marks Pharma and Biotech Convergence 5300 1 CPhI 2009 3A Madrid Launch for BioPh Marks Pharma and Biotech Convergence 5300 2 CPhI 2009 3A Madrid Launch for BioPh Marks Pharma and Biotech Convergence 5300 3 Lab on a Chip Might Speed Breast Cancer Monitoring 59092 1 Lab on a Chip Might Speed Breast Cancer Monitoring 59092 2 Lab on a Chip Might Speed Breast Cancer Monitoring 59092 3

[0] Boston Scientific Announces Election of Nelda Connors to Its Board of Directors [0] CareCentrix Receives URAC Health Utilization Management Accreditation [0] Greenway Medical Technologies' PrimeSuite Wins Three Best in KLAS Awards

... WIRE)--May 24, 2007 - Inovio Biomedical,Corporation (AMEX:INO), ... for cancers and infectious diseases and a ... announced today,that interim clinical trial results demonstrated ... technology was,safe and tolerable, facilitated gene expression, ...

... - Findings from an Otsuka Pharmaceutical Co, ... Association Annual Meeting -, SAN DIEGO, May ... study in,adolescents (13- 17 years old) with ... Squibb Company atypical,antipsychotic aripiprazole demonstrated significant improvement,compared ...

Inovio Biomedical's DNA Delivery Technology Shows Safety and,Enhances Gene Expression & Tumor Responses in Interim Melanoma,Clinical Study Results Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia

(Date:12/17/2009)... Dec. 17 Neurocrine Biosciences, Inc. (Nasdaq: ... a privately negotiated transaction to sell an aggregate of ... of Venrock at a price of $2.09 per share, ... million. Neurocrine expects the financing to close on or ... ,, A shelf registration statement relating to ...

(Date:12/17/2009)... 17 Abaxis, Inc. (Nasdaq: ABAX ... analysis instruments and rapid tests for the medical, ... has entered the production animal diagnostics marketplace with ... Test. This is a USDA-licensed test for Avian ... and ducks. The disposable, non-instrumented device, providing results ...

(Date:12/17/2009)... PricewaterhouseCoopers, Health Research Institute,s Top 10 Health Industry ... control at the head of the list as the ... typically lags trends in the business cycle by a ... new growth for other sectors of the U.S. economy, ... Chin, M.D., partner and leader of PricewaterhouseCoopers, Health Research ...

(Date:12/17/2009)... provide alternative natural relief prior to considering drugs. , ... ... 2009 -- D-Psoria products are the first topical, ... severe skin conditions . Developed by Astrel Genome ... MediNiche Pharmaceuticals, St. Louis, Missouri., , ,D-Psoria products were ...

(Date:12/17/2009)... Stauffer & Nathan law firm, litigators of complex personal injury and ... , ... Tulsa, OK (Lexis Nexis) December 17, 2009 ... than 20 years of experience handling personal injury and insurance coverage ... of the top attorneys in the state of Oklahoma for 2009-2010., ...

Breaking Medicine News(10 mins):Health News:Neurocrine Announces Sale of 4,784,689 Shares of Common Stock, to Raise Proceeds of $10 Million 2 Health News:Neurocrine Announces Sale of 4,784,689 Shares of Common Stock, to Raise Proceeds of $10 Million 3 Health News:ABAXIS(R) Announces Exclusive Worldwide OEM Agreement for a Lateral Flow Avian Influenza Antigen Test Kit 2 Health News:ABAXIS(R) Announces Exclusive Worldwide OEM Agreement for a Lateral Flow Avian Influenza Antigen Test Kit 3 Health News:ABAXIS(R) Announces Exclusive Worldwide OEM Agreement for a Lateral Flow Avian Influenza Antigen Test Kit 4 Health News:Squeezing Costs out of Healthcare Tops PricewaterhouseCoopers' List of Health Industry Issues in 2010 2 Health News:Squeezing Costs out of Healthcare Tops PricewaterhouseCoopers' List of Health Industry Issues in 2010 3 Health News:Squeezing Costs out of Healthcare Tops PricewaterhouseCoopers' List of Health Industry Issues in 2010 4 Health News:Squeezing Costs out of Healthcare Tops PricewaterhouseCoopers' List of Health Industry Issues in 2010 5 Health News:Squeezing Costs out of Healthcare Tops PricewaterhouseCoopers' List of Health Industry Issues in 2010 6 Health News:Squeezing Costs out of Healthcare Tops PricewaterhouseCoopers' List of Health Industry Issues in 2010 7 Health News:Introducing D-Psoria, the First Cosmeceutical Products for the Relief of the Redness, Scaling, and Flaking of Severely Damaged Skin 2 Health News:Introducing D-Psoria, the First Cosmeceutical Products for the Relief of the Redness, Scaling, and Flaking of Severely Damaged Skin 3 Health News:Introducing D-Psoria, the First Cosmeceutical Products for the Relief of the Redness, Scaling, and Flaking of Severely Damaged Skin 4 Health News:Jody Nathan, Highly Regarded Tulsa Attorney, Named to 2009 Oklahoma Super Lawyers List 2

[0] Neurocrine Announces Sale of 4,784,689 Shares of Common Stock, to Raise Proceeds of $10 Million [0] ABAXIS(R) Announces Exclusive Worldwide OEM Agreement for a Lateral Flow Avian Influenza Antigen Test Kit [0] Squeezing Costs out of Healthcare Tops PricewaterhouseCoopers' List of Health Industry Issues in 2010 [0] Introducing D-Psoria, the First Cosmeceutical Products for the Relief of the Redness, Scaling, and Flaking of Severely Damaged Skin [0] Jody Nathan, Highly Regarded Tulsa Attorney, Named to 2009 Oklahoma Super Lawyers List

... a metabolic physiologist at the University of Sherbrooke, Quebec said ... fuelled and provided the essential nutrients to make our brains ... process of brain expansion by eating clams, frogs, bird eggs ... to the explosive brain growth. Our brains weigh roughly twice ...

... anthropology in Arts & Sciences at Washington University in St. ... actually peace loving race in earlier times. // Sussman made ... the Menu," during the American Association for the Advancement of ... ,In his new book "Man the ...

... Chronic Wasting Disease (CWD) in Alberta led to the killing of ... area. This is an effort to curb the spread of chronic ... Ealey said that these measures can prevent the spread of the ... deer among high-risk areas is virtually the only way to reduce ...

... University of Jerusalem researchers report that another health benefit of ... a result it reduces the incidence of heart disease. // ... eat one grapefruit daily can significantly reduce the levels of ... not eat the fruit. This study is relevant in the ...

... the forefront of the mission to translate discoveries in basic ... 13 schools to have been chosen to receive a collective ... ,"The gap between basic biology and medical practice ... and education at the School of Medicine and principal investigator ...

... to possess strong anti-tumor properties in studies conducted on ... cancer patients. // The compound has been found to ... by enhancing the function of enzymes that remove toxins ... been published in the journal Cancer Research. ...

Other Medicine News:Health News:Mystery behind the evolution of the Human brain 2 Health News:Early Man Was A Prey Rather Than A Predator 2 Health News:One fruit that has captured the health benefit sector is Grapefruit! 2 Health News:Getting Basic Science to Work For Medicine 2 Health News:New Compound Offers Hope In Liver Cancer Treatment 2

Mystery behind the evolution of the Human brain Early Man Was A Prey Rather Than A Predator 100 cases of CWD reported in Alberta One fruit that has captured the health benefit sector is Grapefruit!Getting Basic Science to Work For Medicine New Compound Offers Hope In Liver Cancer Treatment

Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...

Medicine Products:

Sinuscope. A4.0AE30 Sinuscope. A4.0AE0 Sinuscope. A1.8AE0 Nagashima Rigid Fiber Optic Antroscope SFA-II

Treprostinil Data to be Presented at Annual Meeting of the American Thorac...( United Therapeutics to Hold Investo...),Health